Federal Bank. Institutional Equities. Management Meet Update

Similar documents
Punjab National Bank

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

Punjab National Bank

9,500 7,914 8, NIM

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN

Gillette India. Institutional Equities. 1QFY18 Result Update

NESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY

Institutional Equities

2,09,057 1,85,859 2,17, (4.1) NIM

Colgate-Palmolive (India)

18,948 15,784 18, NIM

Dalmia Bharat Enterprises

Indian Oil Corporation

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY

Jamna Auto Industries

South Indian Bank. Institutional Equities. 1QFY19 Result Update. Performance Troughs, Pessimism Peaks BUY. 23 July 2018

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

Muthoot Finance. Institutional Equities. 3QFY18 Result Update. Funding Cost Decline Combines With Operating Leverage BUY.

EBITDA 5,076 3, , EBITDA

Manappuram Finance. Institutional Equities. 3QFY18 Result Update. The Glitter Is Back In Gold Loans BUY. 9 February 2018

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

PNB Housing Finance. Institutional Equities. 4QFY18 Result Update BUY. Continued Display of Embedded Scalability. 4 May 2018

Bharat Financial Inclusion

Operating expenses tracked lower than core total income growth as ABL displayed continued

Bata India. Institutional Equities. 1QFY19 Result Update BUY

State Bank of India. Institutional Equities. 3QFY19 Result Update BUY

3,746 2,551 3, NIM

PNB Housing Finance. Institutional Equities. 2QFY19 Result Update BUY. Relatively Soft Quarter Not Structural In Nature.

93,707 77,814 90, NIM

Mold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY

Muthoot Finance. Institutional Equities. 1QFY19 Result Update

Muthoot Finance. Institutional Equities. 2QFY19 Result Update. Weak quarter not structural in any way BUY. 10 December 2018

Muthoot Finance. Institutional Equities. 1QFY18 Result Update. Gold Loan Business Continues To Glitter BUY. 10 August 2017

Institutional Equities

Punjab National Bank

Nestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19%

9,251 7,812 8, NIM

Eicher Motors. Institutional Equities. Management Meet Update BUY. Reuters: EICH.NS; Bloomberg: EIM IN

Punjab National Bank

Indian Oil Corporation

9,807 8,007 9, NIM

Muthoot Finance. Institutional Equities. 2QFY18 Result Update BUY

State Bank of India. Institutional Equities. 1QFY18 Result Update

Institutional Equities

Thermax. Institutional Equities. 3QFY18 Result Update. Healthy Execution, But Margins Disappoint SELL

Punjab National Bank

EBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA

EBITDA 6,223 6,511 (4.4) 5, EBITDA

Voltas. Institutional Equities. 1QFY19 Result Update. EMPS Shines, UCP Proves Its Mettle Again ACCUMULATE

Institutional Equities

Manappuram Finance. Institutional Equities. 2QFY19 Result Update BUY

Manappuram Finance. Institutional Equities. 3QFY17 Result Update BUY

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY

26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN

Institutional Equities

Institutional Equities

Institutional Equities

ACC. Institutional Equities. Event Update. Capacity Expansion To Consolidate Presence In Central India ACCUMULATE

DCB Bank. Institutional Equities. 3QFY19 Result Update. Decisive Move Into Higher RoE Trajectory BUY. 17 January 2019

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE

Hindustan Unilever. Institutional Equities. 1QFY19 Result Update

Hindustan Unilever. Institutional Equities. 4QFY18 Result Update

Axis Bank. Institutional Equities. 3QFY19 Result Update BUY. Management Says 18% RoE In The Realm Of Possibility. 30 January 2019

Dalmia Bharat Enterprises

TVS Motor Company. Institutional Equities. 3QFY19 Result Update SELL

The Ramco Cements. Institutional Equities. Event Update BUY

Dabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE

Institutional Equities

Institutional Equities

Dabur India. Institutional Equities. 1QFY19 Result Update

Bank of Baroda. Institutional Equities. 4QFY18 Result Update BUY

EBITDA 1,548 1,814 (14.7) 1,561 (0.8) EBITDA

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy

Crisil. Institutional Equities. 3QCY17 Result Update ACCUMULATE. Weak SME Rating Revenues & Currency Movement Play Spoilsport

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Sequent Scientific. Institutional Equities. 1QFY19 Result Update BUY

Institutional Equities

Valuation and Outlook. Growth (%) PAT (Rs cr)

Institutional Equities

Institutional Equities

Dalmia Bharat Enterprises

IFB Industries. Institutional Equities. 3QFY18 Result Update. Healthy Revenues, Strong Gross Margin; Retain Buy BUY.

Initiating Coverage. Uflex Ltd.

CARE Ratings. Institutional Equities. 2QFY18 Result Update BUY

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy

EBITDA 1,585 1,917 (17.3) 1,673 (5.2) EBITDA

Bajaj Electricals. Institutional Equities. 3QFY15 Result Update

Institutional Equities

Institutional Equities

Bata India. Institutional Equities. Management Meet Update. On Right Track ACCUMULATE. Sector: Retail CMP: Rs692 Target Price: 696 Upside: 1%

Atul Auto. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Automobile CMP: Rs445 Target Price: Rs489 Upside: 10% 23 August 2017

La Opala RG. Institutional Equities. 4QFY17 Result Update UNDER REVIEW. Revenues Soar, But Margins Take A Hit. Sector: Tableware CMP: Rs536

E&P To Stay Strong; Consumer Segment To Revive

Crompton Greaves. Institutional Equities. 4QFY15 Result Update ACCUMULATE. Overseas Losses Continue; More Business Exits Likely

EBITDA 5,019 4,211 5, EBITDA

Financial summary. Year

Institutional Equities

Swiss Glascoat Equipments

Cadila Healthcare. Institutional Equities. 3QFY15 Result Update UNDER REVIEW. Stable Performance. Sector: Pharmaceuticals CMP: Rs1,514

Transcription:

Management Meet Update Institutional Equities Federal Bank 11 June 2018 Reuters: FED.BO; Bloomberg: FB IN Several Good Things in Store We recently met the CEO of Federal Bank (FBL), Mr Shyam Srinivasan and gleaned incremental insight into the performance and outlook for FBL. (Also, see Detailed Management Meeting Takeways on page 2). Given its outlook and FY19E/20E RoE profile of 11%/12.8%, FBL is a prime re-rating candidate, currently trading at 1.1x FY20E P/BV. It may, also, be noted that 4QFY18 results were mispriced by the market (See results note). Also, see our Initiating Coverage Report. We retain Buy rating on FBL with a target price to Rs116, valuing the stock at 1.5x FY20E P/BV. The CEO explained that the pensioning cost of Federal Bank is on the higher side since most of their employees are still on Defined Benefit Plan. The impact of this will not fade off till FY22/FY23. From 1 st April 2010 onwards, new employees are on NPS, which is a Defined Contribution Plan. The bank aspires to reach a CASA Ratio of ~40% without offering SA interest rate premium. While the bank aims to improve Trade Finance business, the CEO explained that the advantage gleaned from doing Non-fund business would reduce under the IndAS regime. Under IndAS, riskadjusted return or RoRWA will be key. As far as FedFina is concerned, the construction finance book is being unwound and the incremental focus areas will be smaller-ticket loan against property and also, gold loans. Fedfina has a ~Rs 14.5bn book and ~Rs 0.3bn PAT. Rs 1bn of capital has been injected. The CEO stated that Federal Bank had been making more provisions than that mandated by IRAC norms earlier and are now providing as per IRAC. The bank aims to have a PCR of 65-70% including technically written off accounts. The bank aims to have an RoA of 1.2-1.3% by FY20. The target for RoE would be around mid teens. In FY19, an RoA of 1-1.1% and RoE of 10.5-11% could be achieved. The CEO explained the 12 th February Circular mandates concerted action by banks with regard to consortium loans. Independent exposure to the same entity does not warrant concerted action. There is little participation in consortium lending by Federal Bank incrementally. There is about Rs 20bn exposure to legacy consortium loans which are standard and these are not stressed as such. For any sale of IDBI Federal Life, partners IDBI Bank and Ageas need to be on the same page. Ageas has right of first refusal. However, a deal is expected to be struck in due course. The market could value IDBI Federal Life, of which Federal Bank owns 26%, at about Rs 60bn. The CEO envisages gross slippages of about Rs 11-12 bn for the bank over FY19. Retail, SME and Agri are expected to contribute about Rs 2bn each and the balance Rs 5-6bn from corporate book. Recoveries could average about Rs 2.25bn over 3QFY19-4QFY19 About 50% of exposure to 2 key steel sector NCLT accounts could be recovered. 85% of loan book has transitioned to MCLR. The CEO does not expect bond gains in FY19. Currently, the duration is on the lower side at about 2.5 years. The CEO sees interest rates on the higher side. Breakup of transaction value in the bank: Branches: 37%, ATM: 17%, Other Digital (including Internet, Mobile, etc): 46%. Federal Bank s market share in Remittances has risen from ~7% to ~15%. This, the CEO states, is a moat for Federal Bank. Federal Bank has been at the forefront in adopting new technology and they have implemented a blockchain-based money movement platform to further augment Remittance business. On Fee Income growth, the CEO states that, if credit growth would be ~25%, the fee income growth would be ~28%. A new Head of Treasury Sales has been recruited, who has about 20 years of experience with a foreign bank. This is with a view to augment fee income. The rationale for acquiring Equirius was that Federal Bank did not quite have the internal skills for capital markets business. At the moment, Federal Bank has taken a 19.9% stake and could, potentially, take majority stake in the future. The CEO stated that his current term ends in September 2019. He is hoping that it will be renewed. He stated that he has returned his Options back to the bank because he did not wish to hold ~1% stake in the bank. According to the CEO, the next capital requirement for the bank would only come in FY21. The bank is consuming about 30 bps of capital per quarter and they will look to raise when capital levels fall to ~12%. NBIE Values your patronage- Vote for The Team in the Asia Money poll 2018. Click Here BUY Sector: Banking CMP: Rs87 Target Price: Rs116 Upside: 33% Shivaji Thapliyal Research Analyst shivaji.thapliyal@nirmalbang.com +91-22-6273 8068 Key Data Current Shares O/S (mn) 1,972.9 Mkt Cap (Rsbn/US$bn) 175.2/2.6 52 Wk H / L (Rs) 128/80 Daily Vol. (3M NSE Avg.) 14,166,770 Price Performance (%) 1 M 6 M 1 Yr Federal Bank (1.4) (18.0) (24.0) Nifty Index 0.3 5.0 12.1 Source: Bloomberg

Detailed Management Meeting Takeaways The CEO explained that the pensioning cost of Federal Bank is on the higher side since most of their employees are still on Defined Benefit Plan. The impact of this will not fade off till FY22/FY23. From 1 st April 2010 onwards, new employees are on NPS, which is a Defined Contribution Plan. While getting the retail fee income engine moving remains a key aspiration, the CEO explained that strong retail brand take time to fructify and, in this regard, the new version of Federal Bank is 7 years old. In this regard, banks with a larger Deposits base are at an advantage since they naturally obtain a larger Mutual Fund float, for example, an concomitant third party fee income from the same. The bank aspires to reach a CASA Ratio of ~40% without offering SA interest rate premium. While the bank aims to improve Trade Finance business, the CEO explained that the advantage gleaned from doing Non Fund business would reduce under the IndAS regime. Under IndAS, riskadjusted return or RoRWA will be key. The CEO stated that Federal Bank has never had any instance of Divergence with RBI or was insignificant in quantum. As far as FedFina is concerned, it initially began with Gold Loans. Its three areas of focus areas subsequently have been (1) providing distribution for Federal Bank (2) construction finance and (3) loan against property. Currently, the construction finance book is being unwound and the incremental focus areas will be smaller-ticket loan against property and also, gold loans. Fedfina has a ~Rs 14.5bn book and ~Rs 0.3bn PAT. Rs 1bn of capital has been injected into it. The CEO stated that Federal Bank had been making more provisions than that mandated by IRAC norms earlier and are now providing as per IRAC. The bank aims to have a PCR of 65-70% including technically written off accounts. The bank aims to have an RoA of 1.2-1.3% by FY20. The target for RoE would be around mid teens. In FY19, an RoA of 1-1.1% and RoE of 10.5-11% could be achieved. The CEO explained the 12 th February Circular mandates concerted action by banks with regard to consortium loans. Independent exposure to the same entity does not warrant concerted action. There is little participation in consortium lending by Federal Bank incrementally. There is about Rs 20bn exposure to legacy consortium loans which are standard and these are not stressed as such. The CEO stated that there could be pain for the banking system in 1QFY19 as well. For any sale of IDBI Federal Life, partners IDBI Bank and Ageas need to be on the same page. Ageas has right of first refusal. However, a deal is expected to be struck in due course. The market could value IDBI Federal Life, of which Federal Bank owns 26%, at about Rs 60bn. The CEO envisages gross slippages of about Rs 11-12 bn for the bank over FY19. Retail, SME and Agri are expected to contribute about Rs 2bn each and the balance Rs 5-6bn from corporate book. Recoveries could average about Rs 2.25bn over 3QFY19-4QFY19 About 50% of exposure to 2 key steel sector NCLT accounts could be recovered. 85% of loan book has transitioned to MCLR. The salaries of employees below Scale 4 are as per the IBA. These are the unionised employees but are less of an issue now. The hit due to increase in Gratuity Limit increase is about Rs 1.2bn. The CEO does not expect bond gains in FY19. Currently, the duration is on the lower side at about 2.5 years. The CEO sees interest rates on the higher side. Breakup of transaction value in the bank: Branches: 37%, ATM: 17%, Other Digital (including Internet, Mobile, etc): 46%. 2 Federal Bank

The CEO says that while there certainly efficiency gains driven by technology, he also cautions against expecting outsized gains driven by technology. He cites, for example, upward revision of technology charges from software vendors. Federal Bank s market share in Remittances has risen from ~7% to ~15%. This, the CEO states, is a moat for Federal Bank. Federal Bank has been at the forefront in adopting new technology and they have implemented a blockchain-based money movement platform to further augment Remittance business. On Fee Income growth, the CEO states that, if credit growth would be ~25%, the fee income growth would be ~28%. A new Head of Treasury Sales has been recruited, who has about 20 years of experience with a foreign bank. This is with a view to augment fee income. The rationale for acquiring Equirius was that Federal Bank did not quite have the internal skills for capital markets business. At the moment, Federal Bank has taken a 19.9% stake and could, potentially, take majority stake in the future. The CEO stated that his current term ends in September 2019. He is hoping that it will be renewed. He stated that he has returned his Options back to the bank because he did not wish to hold ~1% stake in the bank. According to the CEO, the next capital requirement for the bank would only come in FY21. The bank is consuming about 30 bps of capital per quarter and they will look to raise when capital levels fall to ~12%. The bank tends to operate in 5-year plans. In the first 5-year plan which started in 2010 when the current CEO was appointed, the broad goal was to become more pan-indian. During that phase, the bank opened about 600 branches. About Rs 24bn of capital was raised on 15 th January 2008 at the peak of the stockmarket. That led to some risk-taking on the asset side back then but all these legacy issues have, finally, been dealt with. While SME growth in Kerela has been stunted at ~10%, SME growth outside Kerela has been strong at ~28%. Some Cashew accounts in Kerela are in stress. A hit of Rs 1.1bn has been taken. 3 Federal Bank

Jun-08 Oct-08 Mar-09 Jul-09 Dec-09 Apr-10 Aug-10 Jan-11 May-11 Oct-11 Feb-12 Jul-12 Nov-12 Mar-13 Aug-13 Dec-13 May-14 Sep-14 Feb-15 Jun-15 Oct-15 Mar-16 Jul-16 Dec-16 Apr-17 Sep-17 Jan-18 Jun-18 Institutional Equities Exhibit 1: One-year forward P/BV (x) 2.5 2.0 1.5 1.0 0.5 - Source: Company, Nirmal Bang Institutional Equities Research P/BVPS Mean +1 SD -1 SD +2 SD -2 SD 4 Federal Bank

Financials Exhibit 2: Income statement Y/E March (Rsmn) FY16 FY17 FY18 FY19E FY20E Interest income 77,447 84,460 97,529 117,918 142,078 Interest expenses 52,406 56,248 61,701 74,109 88,937 Net interest income 25,041 28,212 35,829 43,808 53,141 Fee income 5,703 7,731 9,211 12,304 14,998 Other Income 2,161 3,088 2,380 2,719 3,265 Net revenues 32,905 39,031 47,420 58,831 71,404 Operating expenses 18,668 22,095 24,509 29,687 34,465 -Employee expenses 10,529 11,638 12,425 14,307 16,342 -Other expenses 8,139 10,457 12,084 15,380 18,123 Pre-provision profit 14,237 16,936 22,911 29,144 36,939 Provisions 7,041 6,184 8,128 7,794 9,282 -Loan loss provision 5,848 4,836 7,628 7,294 8,782 -Provision for investment 801 242 - - - -Other provisions 392 1,106 500 500 500 PBT 7,196 10,752 14,782 21,350 27,657 Tax 2,440 4,757 4,650 7,259 9,403 PAT 4,756 5,995 10,132 14,091 18,254 Source: Company, Nirmal Bang Institutional Equities Research Exhibit 4: Balance sheet Y/E March (Rsmn) FY16 FY17 FY18 FY19E FY20E Equity Capital 3,438 3,488 3,944 3,944 3,944 Reserves & Surplus 77,476 85,977 118,158 130,580 146,696 Shareholder's Funds 80,914 89,465 122,102 134,524 150,640 Deposits 791,717 976,646 1,119,925 1,384,303 1,681,210 Borrowings 51,145 58,973 115,335 137,070 160,373 Other liabilities 19,898 24,685 25,777 30,443 34,449 Total liabilities 943,674 1,149,769 1,383,140 1,686,341 2,026,672 Cash/Equivalent 54,199 74,530 92,034 113,108 136,860 Advances 580,901 733,363 919,575 1,131,077 1,368,603 Investments 251,548 281,952 307,811 372,064 444,108 Fixed Assets 5,200 4,895 4,574 5,031 5,534 Other assets 51,826 55,029 59,146 65,061 71,567 Total assets 943,674 1,149,769 1,383,140 1,686,341 2,026,672 Source: Company, Nirmal Bang Institutional Equities Research Exhibit 3: Key ratios Y/E March FY16 FY17 FY18 FY19E FY20E Growth (%) NII growth 5.2 12.7 27.0 22.3 21.3 Pre-provision profit growth (12.5) 19.0 35.3 27.2 26.7 PAT growth (52.7) 26.0 69.0 39.1 29.5 Business (%) Deposit growth 11.8 23.4 14.7 23.6 21.4 Advances growth 13.3 26.2 25.4 23.0 21.0 Business growth 12.4 24.6 19.3 23.3 21.2 CD 73.4 75.1 82.1 81.7 81.4 CASA deposit 32.9 32.8 32.5 32.5 32.5 Operating efficiency (%) Cost-to-income 56.7 56.6 51.7 50.5 48.3 Cost-to-assets 2.1 2.1 1.9 1.9 1.9 Productivity (Rsmn) Business per branch 1,096.3 1,365.8 1,629.0 1,931.9 2,255.8 Business per employee 117.0 147.5 175.2 207.7 242.6 Profit per branch 3.8 4.8 8.1 10.8 13.5 Profit per employee 0.4 0.5 0.9 1.2 1.5 Spread (%) Yield on advances 10.4 10.0 9.1 9.0 8.9 Yield on investments 7.1 6.8 6.5 6.5 6.5 Cost of deposits 6.7 6.1 5.6 5.5 5.4 Yield on assets 9.5 8.9 8.4 8.4 8.3 Cost of funds 6.7 6.0 5.4 5.4 5.3 NIM 3.1 3.0 3.1 3.1 3.1 Capital adequacy (%) Tier-I 13.4 11.8 14.2 11.3 10.5 Tier -II 0.6 0.6 0.5 0.5 0.5 Total CAR 13.9 12.4 14.7 11.8 10.9 Asset quality (%) Gross NPAs 2.1 2.3 3.0 2.8 2.7 Net NPAs 1.6 1.3 1.7 1.5 1.5 Provision coverage 24.3 43.7 44.4 45.5 46.5 Provision coverage (Incl. tech w/o) 68.2 70.0 64.4 65.1 64.8 Slippage 3.5 1.6 2.4 1.7 1.7 Credit costs 1.0 0.6 0.8 0.6 0.6 Return ratios (%) RoE 6.0 7.0 9.6 11.0 12.8 RoA 0.5 0.6 0.8 0.9 1.0 RoRWA 0.9 0.9 1.3 1.4 1.5 Per share (Rs) EPS 2.8 3.4 5.1 7.1 9.3 BV 47.1 51.3 61.9 68.2 76.4 ABV 41.5 45.7 54.0 59.5 66.1 Valuation (x) P/E 31.5 25.4 17.0 12.2 9.4 P/BV 1.9 1.7 1.4 1.3 1.1 P/ABV 2.1 1.9 1.6 1.5 1.3 Source: Company, Nirmal Bang Institutional Equities Research 5 Federal Bank

Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Institutional Equities Rating track Date Rating Market price (Rs) Target price (Rs) 26 March 2018 Buy 91 112 10 May 2018 Buy 101 116 11 June 2018 Buy 87 116 Rating track graph 140 130 120 110 100 90 80 70 Not Covered Covered 6 Federal Bank

DISCLOSURES This Report is published by Nirmal Bang Equities Private Limited (hereinafter referred to as NBEPL ) for private circulation. NBEPL is a registered Research Analyst under SEBI (Research Analyst) Regulations, 2014 having Registration no. INH000001436. NBEPL is also a registered Stock Broker with National Stock Exchange of India Limited and BSE Limited in cash and derivatives segments. NBEPL has other business divisions with independent research teams separated by Chinese walls, and therefore may, at times, have different or contrary views on stocks and markets. NBEPL or its associates have not been debarred / suspended by SEBI or any other regulatory authority for accessing / dealing in securities Market. NBEPL, its associates or analyst or his relatives do not hold any financial interest in the subject company. NBEPL or its associates or Analyst do not have any conflict or material conflict of interest at the time of publication of the research report with the subject company. NBEPL or its associates or Analyst or his relatives do not hold beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of this research report. NBEPL or its associates / analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. NBEPL or its associates have not received any compensation or other benefits from the company covered by Analyst or third party in connection with the research report. Analyst has not served as an officer, director or employee of Subject Company and NBEPL / analyst has not been engaged in market making activity of the subject company. Analyst Certification: I, Shivaji Thapliyal, the research analyst is the author of this report, hereby certifies that the views expressed in this research report accurately reflects my personal views about the subject securities, issuers, products, sectors or industries. It is also certified that no part of the compensation of the analyst was, is, or will be directly or indirectly related to the inclusion of specific recommendations or views in this research. The analyst principally responsible for the preparation of this research report and has taken reasonable care to achieve and maintain independence and objectivity in making any recommendations. 7 Federal Bank

Disclaimer Stock Ratings Absolute Returns BUY > 15% ACCUMULATE -5% to15% SELL < -5% This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. NBEPL is not soliciting any action based upon it. Nothing in this research shall be construed as a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any such transaction. In preparing this research, we did not take into account the investment objectives, financial situation and particular needs of the reader. This research has been prepared for the general use of the clients of NBEPL and must not be copied, either in whole or in part, or distributed or redistributed to any other person in any form. If you are not the intended recipient you must not use or disclose the information in this research in any way. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. NBEPL will not treat recipients as customers by virtue of their receiving this report. This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject NBEPL & its group companies to registration or licensing requirements within such jurisdictions. The report is based on the information obtained from sources believed to be reliable, but we do not make any representation or warranty that it is accurate, complete or up-to-date and it should not be relied upon as such. We accept no obligation to correct or update the information or opinions in it. NBEPL or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. NBEPL or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. This information is subject to change without any prior notice. NBEPL reserves its absolute discretion and right to make or refrain from making modifications and alterations to this statement from time to time. Nevertheless, NBEPL is committed to providing independent and transparent recommendations to its clients, and would be happy to provide information in response to specific client queries. Before making an investment decision on the basis of this research, the reader needs to consider, with or without the assistance of an adviser, whether the advice is appropriate in light of their particular investment needs, objectives and financial circumstances. There are risks involved in securities trading. The price of securities can and does fluctuate, and an individual security may even become valueless. International investors are reminded of the additional risks inherent in international investments, such as currency fluctuations and international stock market or economic conditions, which may adversely affect the value of the investment. Opinions expressed are subject to change without any notice. Neither the company nor the director or the employees of NBEPL accept any liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this research and/or further communication in relation to this research. Here it may be noted that neither NBEPL, nor its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profit that may arise from or in connection with the use of the information contained in this report. Copyright of this document vests exclusively with NBEPL. Our reports are also available on our website www.nirmalbang.com Access all our reports on Bloomberg, Thomson Reuters and Factset. Team Details: Name Email Id Direct Line Rahul Arora CEO rahul.arora@nirmalbang.com - Girish Pai Head of Research girish.pai@nirmalbang.com +91 22 3926 8017 / 18 Dealing Ravi Jagtiani Dealing Desk ravi.jagtiani@nirmalbang.com +91 22 3926 8230, +91 22 6636 8833 Pradeep Kasat Dealing Desk pradeep.kasat@nirmalbang.com +91 22 3926 8100/8101, +91 22 6636 8831 Michael Pillai Dealing Desk michael.pillai@nirmalbang.com +91 22 3926 8102/8103, +91 22 6636 8830 Nirmal Bang Equities Pvt. Ltd. Correspondence Address B-2, 301/302, Marathon Innova, Nr. Peninsula Corporate Park, Lower Parel (W), Mumbai-400013. Board No. : 91 22 3926 8000/1; Fax. : 022 3926 8010 8 Federal Bank